CA19-9 / Sialyl Lewisa (GI Tumor Marker) Antibody - With BSA and Azide
Mouse Monoclonal Antibody [Clone SPM588 ]
- 产品详情
- 实验流程
- 背景知识
Application ![]()
| IHC, IF, FC |
---|---|
Reactivity | Human |
Host | Mouse |
Clonality | Monoclonal |
Isotype | Mouse / IgM, kappa |
Clone Names | SPM588 |
Calculated MW | 400 KDa |
Application Note | IHC~~1:100~500 IF~~1:50~200 FC~~1:10~50 |
---|---|
Storage | Store at 2 to 8°C.Antibody is stable for 24 months. |
Precautions | CA19-9 / Sialyl Lewisa (GI Tumor Marker) Antibody - With BSA and Azide is for research use only and not for use in diagnostic or therapeutic procedures. |
For Research Use Only. Not For Use In Diagnostic Procedures.
Provided below are standard protocols that you may find useful for product applications.
BACKGROUND
CA19-9, a carbohydrate epitope expressed on a high MW (>400kDa) mucin glycoprotein, is a sialyl Lewisa structure which is synthesized from type 1 blood group precursor chains and is present in individuals expressing the Lewisa and/or Lewisb blood group antigens. In normal tissues, sialyl Lewisa antigen is present in ductal epithelium of the breast, kidney, salivary gland, and sweat glands. Its expression is greatly enhanced in serum as well as in the majority of tumor cells in gastrointestinal (GI) carcinomas, including adenocarcinomas of the stomach, intestine, and pancreas. Preoperative elevated CA19-9 levels in patients with stage I pancreatic carcinoma decrease to normal values following surgery. When used serially, CA19-9 can predict recurrence of disease prior to radiographic or clinical findings. This MAb is superb for staining of formalin-fixed, paraffin-embedded tissues.
REFERENCES
Norden R et al. Glycobiology 23:310-21 (2013)

终于等到您。ABCEPTA(百远生物)抗体产品。
点击下方“我要评价 ”按钮提交您的反馈信息,您的反馈和评价是我们最宝贵的财富之一,
我们将在1-3个工作日内处理您的反馈信息。
如有疑问,联系:0512-88856768 tech-china@abcepta.com.